Spirotryprostatin B, a novel mammalian cell cycle inhibitor produced by Aspergillus fumigatus [1]

Journal of Antibiotics

Volumn 49, Issue 8, 1996, Pages 832-835

  Cui, Cheng Bin ^a   Kakeya, Hideaki ^a   Osada, Hiroyuki ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; SPIROTRYPROSTATIN B; UNCLASSIFIED DRUG;

ASPERGILLUS FUMIGATUS; CARBON NUCLEAR MAGNETIC RESONANCE; CELL CYCLE G2 PHASE; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFRARED SPECTROMETRY; LETTER; METAPHASE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY;

EID: 0029820050     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.49.832     Document Type: Letter

References (11)

1. CUI, C.-B.; H. KAKEYA, G. OKADA, R. ONOSE, M. UBUKATA, I. TAKAHASHI, K. ISONO & H. OSADA: Tryprostatins A and B, novel mammalian cell cycle inhibitors produced by Aspergillus fumigatus. J. Antibiotics 48: 1382-1384, 1995
2. CUI, C.-B.; H. KAKEYA, G. OKADA, R. ONOSE & H. OSADA: Novel mammalian cell cycle inhibitors, tryprostatins A, B and other diketopiperazines produced by Aspergillus fumigatus. I. Taxonomy, fermentation, isolation and biological properties. J. Antibiotics 49: 527-533, 1996
3. CUI, C.-B.; H. KAKEYA & H. OSADA: Novel mammalian cell cycle inhibitors, tryprostatins A, B and other diketopiperazines produced by Aspergillus fumigatus. II. Physico-chemical properties and structures. J. Antibiotics 49: 534-540, 1996
4. MINEO, C.; Y. MURAKAMI, Y. ISHIMI, F. HANAOKA & M.-A. YAMADA: Isolation and analysis of a mammalian temperature-sensitive mutant defective in G2 functions. Exp. Cell Res. 167: 53-62, 1986
5. TH'NG, J. P. H.; P. S. WRIGHT, J. HAMAGUCHI, M. G. LEE, C. J. NORBURY, P. NURSE & E. M. BRADBURY: The FT210 cell line is a mouse G2 phase mutant with a temperature-sensitive CDC2 gene product. Cell 63: 313-324, 1990
6. STEYN, P. S.: The structures of five diketopiperazines from Aspergillus ustus. Tetrahedron 29: 107-120, 1973
7. STEYN, P. S.: Austamide, a new toxic metabolite from Aspergillus ustus. Tetrahedron Lett. 1971: 3331-3334, 1971
8. BIRCH, A. J. & J. J. WRIGHT: Studies in relation to biosynthesis-XLII, The structural elucidation and some aspects of the biosynthesis of the brevianamide-A and -E. Tetrahedron 26: 2329-2344, 1970
9. RAO, C. N. R.: Chemical Applications of Infrared Spectroscopy. pp. 258-261, Academic Press Inc., New York, 1963
10. WILLIAMS, R. M.; E. K. H. COFFMAN & T. GLINKA: Remarkable, enantiodivergent biogenesis of brevianamide A and B. J. Am. Chem. Soc. 111: 3064-3065, 1989
11. STEYN, P. S. & R. VLEGGAAR: Tremorgenic mycotoxins. Progress in the Chemistry of Organic Natural Products (Founded by L. ZECHMIESTER, Edited by W. HERZ, H. GRISEBACH and G. W. KIRBY). 48: 1-80, 1985